Medical Pharma, Inc. (OTCQB: TRGM) announced today that it has been
selected as one of the best six stocks in the microcap space by industry
a division of Wall-Street Media Co.
"We have worked very hard to be in a position to gain this type of
recognition, and it is an honor to be chosen as one of the best six
stocks by the industry specialist Wall-Street.com," said William Shell,
M.D., CEO and Chief Scientific Officer of Targeted Medical Pharma, Inc.
"Many of the companies Wall-Street.com ranks in their top 15 percent
stand an excellent chance of delivering immense value to their
shareholders, and we intend to achieve that goal by continuing to
execute our business strategy."
Wall-Street.com was established in 1994 as one of the first financial
websites dedicated to covering the growing microcap space.
Wall-Street.com focuses on providing investors with detailed financial
and industry information regarding microcap companies. Wall-Street.com
was acquired by Wall-Street Media Co. in 2011.
About Targeted Medical Pharma, Inc.
Medical Pharma, Inc. is a Los Angeles-based biotechnology company
that develops medical
foods for the treatment of chronic disease, including pain
syndromes, peripheral neuropathy, hypertension, obesity, sleep and
cognitive disorders. The company also develops a line of dietary
supplements designed to support health and wellness. The company
manufactures 10 proprietary medical foods, 48 convenience kits and
recently launched its first dietary supplement, Clearwayz™.
The products are sold directly to physicians and pharmacies in the U.S.
The company also is developing nutrient-based systems for oral
stimulation of progenitor stem cells that differentiate into neurons,
red blood cells, pituitary hormones including IGF-I.
Forward Looking Statement
This press release may contain forward-looking statements related to
Targeted Medical Pharma's business strategy, outlook, objectives, plans,
intentions or goals. The words "may," "will," "should," "plans,"
"explores," "expects," "anticipates," "continue," "estimate," "project,"
"intend," and similar expressions, identify forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of
1995, but their absence does not mean that the statement is not
forward-looking. These statements are not guarantees of future
performance and are subject to certain risks, uncertainties, and
assumptions that are difficult to predict. Actual results could differ
materially. Targeted Medical Pharma expressly disclaims any obligation
or undertaking to update or revise any forward-looking statement
contained herein to reflect any change in the company's expectations
with regard thereto or any change in events, conditions or circumstances
upon which any statement is based.
[ Back To NFVZone's Homepage ]